688710 益诺思
已收盘 05-19 15:00:01
资讯
新帖
简况
益诺思(688710)披露2025年年度股东会会议资料,5月19日股价下跌3.55%
证券之星 · 05-19 22:47
益诺思(688710)披露2025年年度股东会会议资料,5月19日股价下跌3.55%
益诺思(688710)披露股东询价转让定价情况提示性公告,5月18日股价上涨1.79%
证券之星 · 05-18 18:57
益诺思(688710)披露股东询价转让定价情况提示性公告,5月18日股价上涨1.79%
股市必读:5月15日益诺思发生2笔大宗交易 成交金额494.76万元
证券之星 · 05-18 04:01
股市必读:5月15日益诺思发生2笔大宗交易 成交金额494.76万元
每周股票复盘:益诺思(688710)股东拟减持2.50%股份
证券之星 · 05-17 03:39
每周股票复盘:益诺思(688710)股东拟减持2.50%股份
益诺思(688710)2026年一季报简析:营收净利润同比双双增长,存货明显上升
证券之星 · 05-01
益诺思(688710)2026年一季报简析:营收净利润同比双双增长,存货明显上升
益诺思(688710)3月31日股东户数0.41万户,较上期减少12.56%
证券之星 · 04-30
益诺思(688710)3月31日股东户数0.41万户,较上期减少12.56%
图解益诺思年报:第四季度单季净利润同比下降204.90%
证券之星 · 04-30
图解益诺思年报:第四季度单季净利润同比下降204.90%
3月30日益诺思涨5.77%,招商医药健康产业股票基金重仓该股
证券之星 · 03-30
3月30日益诺思涨5.77%,招商医药健康产业股票基金重仓该股
每周股票复盘:益诺思(688710)股东减持1.00%股份,持股比例降至11.35%
证券之星 · 03-29
每周股票复盘:益诺思(688710)股东减持1.00%股份,持股比例降至11.35%
3月27日益诺思涨14.57%,招商医药健康产业股票基金重仓该股
证券之星 · 03-27
3月27日益诺思涨14.57%,招商医药健康产业股票基金重仓该股
3月25日益诺思发布公告,股东减持89.78万股
证券之星 · 03-25
3月25日益诺思发布公告,股东减持89.78万股
3月18日益诺思涨5.73%,招商医药健康产业股票基金重仓该股
证券之星 · 03-18
3月18日益诺思涨5.73%,招商医药健康产业股票基金重仓该股
3月5日益诺思涨10.21%,招商医药健康产业股票基金重仓该股
证券之星 · 03-05
3月5日益诺思涨10.21%,招商医药健康产业股票基金重仓该股
3月3日益诺思跌9.64%,招商医药健康产业股票基金重仓该股
证券之星 · 03-03
3月3日益诺思跌9.64%,招商医药健康产业股票基金重仓该股
每周股票复盘:益诺思(688710)2025年净利亏损3051.59万元
证券之星 · 03-01
每周股票复盘:益诺思(688710)2025年净利亏损3051.59万元
益诺思发布2025年度业绩快报,亏损0.305亿元
证券之星 · 02-27
益诺思发布2025年度业绩快报,亏损0.305亿元
2月3日益诺思涨7.52%,招商医药健康产业股票基金重仓该股
证券之星 · 02-03
2月3日益诺思涨7.52%,招商医药健康产业股票基金重仓该股
益诺思(688710)披露筹划股权收购暨关联交易的提示性公告,1月30日股价上涨0.91%
证券之星 · 01-30
益诺思(688710)披露筹划股权收购暨关联交易的提示性公告,1月30日股价上涨0.91%
1月22日益诺思涨5.96%,招商医药健康产业股票基金重仓该股
证券之星 · 01-22
1月22日益诺思涨5.96%,招商医药健康产业股票基金重仓该股
每周股票复盘:益诺思(688710)股东减持51.2万股触及1%变动
证券之星 · 01-18
每周股票复盘:益诺思(688710)股东减持51.2万股触及1%变动
加载更多
公司概况
公司名称:
上海益诺思生物技术股份有限公司
所属行业:
研究和试验发展
上市日期:
2024-09-03
主营业务:
上海益诺思生物技术股份有限公司的主营业务是提供生物医药非临床研究服务为主的综合研发服务(CRO)。公司的主要产品是非临床CRO、临床CRO。公司荣膺医药魔方“中国创新药十年荣耀榜·行业引领CRO公司”、药融圈“中国新药临床前CRO排名TOP20”、每日经济新闻“2025上市公司最具社会责任奖”、《证券市场周刊》“金曙光新质生产力奖”等系列荣誉,并凭借在体内CAR-T领域的突出贡献,成为同写意“体内CAR-T新基建联盟成员机构”;同时获评石药集团“2025最佳合作单位”。
发行价格:
19.06
{"stockData":{"symbol":"688710","market":"SH","secType":"STK","nameCN":"益诺思","latestPrice":63.49,"timestamp":1779174001000,"preClose":65.83,"halted":0,"volume":2356626,"delay":0,"changeRate":-0.0355,"floatShares":90694000,"shares":141000000,"eps":-0.1691,"marketStatus":"已收盘","change":-2.34,"latestTime":"05-19 15:00:01","open":67.15,"high":69.7,"low":62.99,"amount":156000000,"amplitude":0.1019,"askPrice":63.49,"askSize":4,"bidPrice":63.47,"bidSize":2,"shortable":0,"etf":0,"ttmEps":-0.1691,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779240600000},"marketStatusCode":5,"adr":0,"adjPreClose":65.83,"symbolType":"stock_kcb","openAndCloseTimeList":[[1779154200000,1779161400000],[1779166800000,1779174000000]],"highLimit":72.41,"lowLimit":59.25,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":140979615,"isCdr":false,"pbRate":3.83,"roa":"--","roe":"0.52%","epsLYR":-0.22,"committee":0.258065,"marketValue":8951000000,"turnoverRate":0.026,"status":1,"afterMarket":{"amount":0,"volume":0,"close":63.49,"buyVolume":6000,"sellVolume":0,"time":1779176037558,"indexStatus":"已收盘 05-19 15:30:00","preClose":65.83},"floatMarketCap":5758000000},"requestUrl":"/m/hq/s/688710","defaultTab":"news","newsList":[{"id":"2636985712","title":"益诺思(688710)披露2025年年度股东会会议资料,5月19日股价下跌3.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636985712","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636985712?lang=zh_cn&edition=full","pubTime":"2026-05-19 22:47","pubTimestamp":1779202032,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘,益诺思报收于63.49元,较前一交易日下跌3.55%,最新总市值为89.51亿元。该股当日开盘67.15元,最高69.7元,最低62.99元,成交额达1.56亿元,换手率为2.6%。近日,上海益诺思生物技术股份有限公司披露《2025年年度股东会会议资料》。公告显示,公司拟召开2025年年度股东会,审议2025年度董事会工作报告、利润分配方案、“十五五”发展规划、2026年度日常关联交易预计及董事2025年度薪酬等议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900044257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636279690","title":"益诺思(688710)披露股东询价转让定价情况提示性公告,5月18日股价上涨1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636279690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636279690?lang=zh_cn&edition=full","pubTime":"2026-05-18 18:57","pubTimestamp":1779101833,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘,益诺思报收于65.83元,较前一交易日上涨1.79%,最新总市值为92.81亿元。该股当日开盘65.25元,最高68.72元,最低63.02元,成交额达1.93亿元,换手率为3.21%。近日,公司披露《股东询价转让定价情况提示性公告》。参与报价的机构投资者共32家,有效认购股份数量为7,488,000股,有效认购倍数约为2.12倍。本次询价转让拟转让股份已获全额认购,初步确定受让方为14家机构投资者,拟受让股份总数为3,528,094股。本次转让不涉及公司控制权变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800030100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636016969","title":"股市必读:5月15日益诺思发生2笔大宗交易 成交金额494.76万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2636016969","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636016969?lang=zh_cn&edition=full","pubTime":"2026-05-18 04:01","pubTimestamp":1779048076,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,益诺思报收于64.67元,上涨2.29%,换手率2.46%,成交量2.23万手,成交额1.45亿元。大宗交易5月15日益诺思发生2笔大宗交易,成交金额494.76万元。股东询价转让计划书上海益诺思生物技术股份有限公司股东张江生药基地拟通过询价转让方式减持公司股份3,528,094股,占公司总股本的2.50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800001660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636064245","title":"每周股票复盘:益诺思(688710)股东拟减持2.50%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2636064245","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636064245?lang=zh_cn&edition=full","pubTime":"2026-05-17 03:39","pubTimestamp":1778960350,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,益诺思报收于64.67元,较上周的65.12元下跌0.69%。本周,益诺思5月15日盘中最高价报67.05元。出让方为合法存续的国有控股企业,非益诺思控股股东或董监高,拟转让股份为首发前股份且无质押、冻结等权利受限情形,已履行必要审批程序,符合《询价转让和配售指引》规定的相关资格要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660266","title":"益诺思(688710)2026年一季报简析:营收净利润同比双双增长,存货明显上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660266","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632660266?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:52","pubTimestamp":1777589548,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期益诺思发布2026年一季报。截至本报告期末,公司营业总收入2.1亿元,同比上升0.43%,归母净利润1220.86万元,同比上升121.23%。本报告期益诺思存货明显上升,存货同比增幅达34.32%。持有益诺思最多的基金为平安医疗健康混合A,目前规模为17.03亿元,最新净值2.2908,较上一交易日下跌1.07%,近一年上涨7.9%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100007461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631684968","title":"益诺思(688710)3月31日股东户数0.41万户,较上期减少12.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631684968","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631684968?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:36","pubTimestamp":1777541761,"startTime":"0","endTime":"0","summary":"证券之星消息,近日益诺思披露,截至2026年3月31日公司股东户数为4079.0户,较12月31日减少586.0户,减幅为12.56%。在医疗服务行业个股中,益诺思股东户数低于行业平均水平,截至3月31日,医疗服务行业平均股东户数为4.9万户。从股价来看,2025年12月31日至2026年3月31日,益诺思区间涨幅为60.82%,在此期间股东户数减少586.0户,减幅为12.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000056629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631544291","title":"图解益诺思年报:第四季度单季净利润同比下降204.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631544291","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631544291?lang=zh_cn&edition=full","pubTime":"2026-04-30 01:01","pubTimestamp":1777482117,"startTime":"0","endTime":"0","summary":"证券之星消息,益诺思2025年年报显示,当年度公司主营收入8.11亿元,同比下降28.94%;归母净利润-3051.59万元,同比下降120.65%;扣非净利润-5389.68万元,同比下降142.98%;其中2025年第四季度,公司单季度主营收入2.41亿元,同比下降7.17%;单季度归母净利润-1572.78万元,同比下降204.9%;单季度扣非净利润-1913.74万元,同比下降506.29%;负债率27.4%,财务费用-850.09万元,毛利率25.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000003262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623397215","title":"3月30日益诺思涨5.77%,招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623397215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623397215?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:27","pubTimestamp":1774859223,"startTime":"0","endTime":"0","summary":"证券之星消息,3月30日益诺思涨5.77%创60日新高,收盘报69.8元,换手率3.36%,成交量3.05万手,成交额2.13亿元。重仓益诺思的前十大公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共12家,其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。该公募基金现任基金经理为李佳存。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000021521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623836333","title":"每周股票复盘:益诺思(688710)股东减持1.00%股份,持股比例降至11.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623836333","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623836333?lang=zh_cn&edition=full","pubTime":"2026-03-29 03:54","pubTimestamp":1774727651,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘,益诺思报收于65.99元,较上周的52.13元上涨26.59%。公司公告汇总股东减持股份结果公告本次减持计划实施前,翱鹏合伙持有上海益诺思生物技术股份有限公司17,412,396股,占公司总股本的12.35%。翱鹏合伙于2026年1月14日至3月24日通过集中竞价方式减持公司股份1,409,796股,占公司总股本的1.00%。本次减持计划已实施完毕,减持后翱鹏合伙持股数量为16,002,600股,持股比例降至11.35%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622849336","title":"3月27日益诺思涨14.57%,招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622849336","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622849336?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:14","pubTimestamp":1774599270,"startTime":"0","endTime":"0","summary":"证券之星消息,3月27日益诺思涨14.57%,收盘报65.99元,换手率3.7%,成交量3.36万手,成交额2.15亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700033412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622024439","title":"3月25日益诺思发布公告,股东减持89.78万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622024439","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622024439?lang=zh_cn&edition=full","pubTime":"2026-03-25 18:01","pubTimestamp":1774432914,"startTime":"0","endTime":"0","summary":"证券之星消息,3月25日益诺思发布公告《益诺思:股东减持股份结果公告》,其股东上海翱鹏企业管理中心(有限合伙)于2026年1月17日至2026年3月24日间合计减持89.78万股,占公司目前总股本的0.6368%,变动期间该股股价下跌12.52%,截止3月24日收盘报55.25元。股东增减持详情见下表:根据益诺思2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500035632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620233060","title":"3月18日益诺思涨5.73%,招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620233060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620233060?lang=zh_cn&edition=full","pubTime":"2026-03-18 16:14","pubTimestamp":1773821699,"startTime":"0","endTime":"0","summary":"证券之星消息,3月18日益诺思涨5.73%,收盘报58.52元,换手率1.79%,成交量1.62万手,成交额9360.93万元。重仓益诺思的前十大公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800027118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617514929","title":"3月5日益诺思涨10.21%,招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2617514929","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617514929?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:28","pubTimestamp":1772699282,"startTime":"0","endTime":"0","summary":"证券之星消息,3月5日益诺思涨10.21%,收盘报52.57元,换手率2.97%,成交量2.7万手,成交额1.37亿元。重仓益诺思的前十大公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。该公募基金现任基金经理为李佳存。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500025891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616231750","title":"3月3日益诺思跌9.64%,招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2616231750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616231750?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:42","pubTimestamp":1772527337,"startTime":"0","endTime":"0","summary":"证券之星消息,3月3日益诺思跌9.64%,收盘报49.69元,换手率4.22%,成交量3.83万手,成交额1.96亿元。重仓益诺思的前十大公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。该公募基金现任基金经理为李佳存。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300029171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616884309","title":"每周股票复盘:益诺思(688710)2025年净利亏损3051.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616884309","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616884309?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:27","pubTimestamp":1772303230,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,益诺思报收于57.8元,较上周的56.29元上涨2.68%。本周,益诺思2月27日盘中最高价报59.8元。本周关注点业绩披露要点:益诺思2025年归属净利润亏损3,051.59万元,同比减少120.65%。公司公告汇总上海益诺思生物技术股份有限公司发布2025年度业绩快报,营业总收入81,132.52万元,同比下降28.94%;营业利润-1,288.62万元,同比下降108.10%;利润总额-1,629.88万元,同比下降110.26%;归属于母公司所有者的净利润-3,051.59万元,同比下降120.65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614831340","title":"益诺思发布2025年度业绩快报,亏损0.305亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614831340","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614831340?lang=zh_cn&edition=full","pubTime":"2026-02-27 18:11","pubTimestamp":1772187076,"startTime":"0","endTime":"0","summary":"证券之星消息,益诺思近日即将发布2025年年报,根据2月27日发布的业绩快报,归属净利润亏损0.305亿元,同比减少120.65%。报告期末,公司总资产 325,342.98 万元,较期初增长 1.05%;报告期末,归属于母公司的所有者权益为 232,343.58 万元,较期初减少 2.86%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700032090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608482507","title":"2月3日益诺思涨7.52%,招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608482507","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608482507?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:42","pubTimestamp":1770108148,"startTime":"0","endTime":"0","summary":"根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。李佳存在任的基金产品包括:招商创新增长混合A,管理时间为2020年6月17日至今,期间收益率为-17.95%;招商前沿医疗保健股票A,管理时间为2021年6月22日至今,期间收益率为-39.09%;招商品质成长混合A,管理时间为2021年9月23日至今,期间收益率为-20.67%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300028125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607449110","title":"益诺思(688710)披露筹划股权收购暨关联交易的提示性公告,1月30日股价上涨0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607449110","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607449110?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:58","pubTimestamp":1769785094,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,益诺思报收于58.6元,较前一交易日上涨0.91%,最新总市值为82.61亿元。该股当日开盘58.05元,最高60.0元,最低56.12元,成交额达9747.16万元,换手率为1.86%。近日,上海益诺思生物技术股份有限公司发布《关于筹划股权收购暨关联交易的提示性公告》。本次交易构成关联交易,预计不构成重大资产重组,采用现金方式,不涉及发行股份,不会导致公司控制权变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000047833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605638694","title":"1月22日益诺思涨5.96%,招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605638694","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605638694?lang=zh_cn&edition=full","pubTime":"2026-01-22 15:35","pubTimestamp":1769067344,"startTime":"0","endTime":"0","summary":"证券之星消息,1月22日益诺思涨5.96%,收盘报66.35元,换手率1.59%,成交量1.44万手,成交额9269.41万元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200019621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604257169","title":"每周股票复盘:益诺思(688710)股东减持51.2万股触及1%变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2604257169","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604257169?lang=zh_cn&edition=full","pubTime":"2026-01-18 04:34","pubTimestamp":1768682049,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘,益诺思报收于63.16元,较上周的63.59元下跌0.68%。本周,益诺思1月13日盘中最高价报72.0元,股价触及近一年最高点。本周关注点股本股东变化:股东上海翱鹏减持51.2万股,持股比例降至11.99%公司公告汇总:本次减持系履行已披露计划,不触发要约收购股本股东变化股东增减持1月16日公告,上海翱鹏企业管理中心于1月14日至1月16日减持51.2万股,占总股本0.3632%。本次权益变动后,持股比例由12.35%下降至11.99%,触及1%的整数倍标准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779217624913,"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0655},{"period":"3month","weight":0.1279},{"period":"6month","weight":0.3677},{"period":"1year","weight":1.0578},{"period":"ytd","weight":0.4381}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0292},{"period":"3month","weight":0.0214},{"period":"6month","weight":0.0607},{"period":"1year","weight":0.2381},{"period":"ytd","weight":0.0506}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海益诺思生物技术股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"4079人(较上一季度减少12.56%)","perCapita":"22234股","listingDate":"2024-09-03","address":"上海市浦东新区中国(上海)自由贸易试验区郭守敬路199号106室","registeredCapital":"14097万元","survey":" 上海益诺思生物技术股份有限公司的主营业务是提供生物医药非临床研究服务为主的综合研发服务(CRO)。公司的主要产品是非临床CRO、临床CRO。公司荣膺医药魔方“中国创新药十年荣耀榜·行业引领CRO公司”、药融圈“中国新药临床前CRO排名TOP20”、每日经济新闻“2025上市公司最具社会责任奖”、《证券市场周刊》“金曙光新质生产力奖”等系列荣誉,并凭借在体内CAR-T领域的突出贡献,成为同写意“体内CAR-T新基建联盟成员机构”;同时获评石药集团“2025最佳合作单位”。","listedPrice":19.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"益诺思(688710)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供益诺思(688710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"益诺思,688710,益诺思股票,益诺思股票老虎,益诺思股票老虎国际,益诺思行情,益诺思股票行情,益诺思股价,益诺思股市,益诺思股票价格,益诺思股票交易,益诺思股票购买,益诺思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"益诺思(688710)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供益诺思(688710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}